Professional Documents
Culture Documents
Quality Assurance & GMP
Quality Assurance & GMP
GMP
Quality CONTROL
2
Quality
Signifies excellence of product /service
which is based on consumers experience
with the product /service against his or
her requirement.
DEFINITIONS
• Quality is the totality of features and characteristics of a product or
service that bear on its ability to satisfy given needs (ASQ) and/or
implied needs
Value to the Customers
such way that , they assure the management that the activity
Quality control is
Everyone in the team usually the
involved in developing the responsibility of a
Responsibility
product is responsible for specific team that
quality assurance. tests the product for
defects.
Validation/Software
Verification is an example
Example Testing is an example
of QA
of QC
QC is a corrective
As a tool QA is a managerial tool
tool
QC is product
Orientation QA is process oriented
oriented
15
Quality Assurance
Primary Functions
• Quality Control
• Analytical testing of products
16
Elements of the Quality Assurance Cycle in
Pharmaceutical Manufacturing
• Research
• Development
• Documentation
• Raw Materials
• Facilities
• Equipment
• Personnel and Supervision
• Monitoring, Feedback, Follow-up
17
Quality Assurance: Essential At All Stages
Research
Development
Raw Materials
Facilities
Documentation
Equipment
Personnel
18
Quality relationships
QA
GMP
QC
19
GMP
Part of Quality Assurance which ensures that products are
constantly produced and control to the quality standards
appropriate to their intended use and required by the
marketing authorization.
21
The Breadth of GMP
23
WHO Technical Guide to GMP
• First prepared in 1967
• Updated and revised regularly
• “Quality Management in the Drug Industry” outlines
general concepts and principle components of GMP
• “Good practices in production and quality control”
describes implementation
24
WHO Technical Guide to GMP
General Consideration
“Licensed pharmaceutical products should be
manufactured only by licensed manufacturers whose
activities are regularly inspected by competent national
authorities”
25
WHO Technical Guide to GMP
Key Concepts
• Validation
Action of proving (in accordance with principles of
GMP) that any procedure, process, equipment,
material, activity, or system actually leads to
expected results
26
WHO Technical Guide to GMP
Key Concepts
• Qualification
Action of proving that any premises, system, and
items of equipment work correctly and actually lead
to expected results
27
Key Elements of GMP
(WHO Technical Guide)
28
Key Elements of GMP (WHO Technical Guide)
Personnel
(Training, Hygiene)
Documentation Premises
(Equipment)
Materials
(Supplies, Ingredients)
29
GLP (Good Laboratory Practices)
Need to be used in laboratory.
Purpose
31
Quality relationships
Quality Management
Quality Assurance
GMP
Quality Control
36
FACTORS IN DRUG QUALITY ASSURANCE
MANUFACURING
LEGISLATIVE PROCESSES
FRAMEWORK & PROCEDURES QC &
-REGULATIONS ANALYSIS
HUMAN
RESOURCES-
PROFESSIONALS STORAGE
DRUG
RAW PRODUCT
MATERIALS- QUALITY
ACTIVE & PACKAGING
INACTIVE
LABELLING &
IMPORT PRODUCT
TRANSPORT INFROMATION
& EXPORT
DISTRIBUTION
CONTROL
DISPENSING
& USE 37
GCP (Good Clinical Practices)
Set of Guidelines for biomedical studies.
Aim
To ensure that the studies are scientifically &
ethically sound.
Investigations are properly documented.
Protection of rights of human subjects in clinical
trials.
Authenticity of biomedical data generated under
biomedical study.
Quality Must Be Designed Into A Product
40
Manufacturing Process and Procedures
• Dispensing / Weighing
• Mixing / Granulation / Preparation
• Compression / Encapsulation / Filling
• Equipment, Operational & Process
Qualification
• Validation & calibration
• Documentation and record keeping
• Yield Reconciliation
41
Stability Definitions (1)
• Capability of a particular formulation of a
pharmaceutical in a specified container/closure
system to remain within specified physical, chemical,
microbiological, therapeutic and toxicological
specifications
43
Stability Definitions (2)
• The time from the date of manufacture and
packaging of the formulation until its chemical or
biological activity is not less than a predetermined
level (generally, 90%) of labeled potency and its
physical characteristics have not changed appreciably
44